Podcasts

Ketamine for treatment-resistant depression

Current Psychiatry. 2016 July;15(7)
By
Jonathan M. Meyer, MD
Author and Disclosure Information

Jonathan M. Meyer, MD, discusses the pros and cons of using ketamine and other glutamate-based strategies for patients with treatment-resistant unipolar and bipolar depression.

 

Recommended Reading

Does medical marijuana work for PTSD, other psychiatric indications?
MDedge Psychiatry
Study finds most antidepressants ineffective or harmful in children, adolescents
MDedge Psychiatry
Weighty issues: Exploring the connection between diabetes, depression
MDedge Psychiatry
Distress or depression in a 12-year-old girl?
MDedge Psychiatry
Low-field magnetic stimulation fails to improve refractory depression
MDedge Psychiatry
Alternative therapies can augment treatment in resistant depression
MDedge Psychiatry
Primary care management of sepsis survivors does not improve mental health quality of life
MDedge Psychiatry
No evidence of pregnancy, but she is suicidal and depressed after ‘my baby died’
MDedge Psychiatry
How to talk to patients and families about brain stimulation
MDedge Psychiatry
Escitalopram falls short in patients with heart failure and depression
MDedge Psychiatry